BFM
HALO icon

Boothbay Fund Management’s Halozyme HALO Stock Holding History

Boothbay Fund Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,296
Closed -$303K – 1671
2024
Q3 		$303K Buy
+5,296
New +$304K 0.01% 1231
2019
Q1 		– Sell
-26,000
Closed -$380K – 802
2018
Q4 		$380K Buy
+26,000
New +$415K 0.06% 335

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boothbay Fund Management's HALO Position: Q4 2024 in Review

Boothbay Fund Management sold out of Halozyme (HALO) in Q4 2024, closing a stake of 5,296 shares — an estimated $303K sold.

Boothbay Fund Management first reported a position in HALO in Q4 2018 and held it in 2 quarters. The position peaked at $380K in Q4 2018. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

  • Boothbay Fund Management reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 5,296 Halozyme shares in Q4 2024, an estimated $303K.
  • Boothbay Fund Management first reported a position in Halozyme in Q4 2018 and held it in 2 quarters.
  • Boothbay Fund Management's Halozyme position peaked at $380K in Q4 2018.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on Boothbay Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.